Allo Admedus!

In the words of Alice in Wonderland, it all gets “Curioser and Curioser”. Admedus is a fledgling healthcare stock on course to make its mark globally, but the market is unconvinced that this will happen anytime soon. Time and again,… Read More ›

The Admedus puzzle

This week marked the third anniversary of my holding in the biotech stock Admedus. I have shared with readers its fluctuating fortunes in this time, striving to present its prospects in as objective a manner as possible. I have taken… Read More ›